CMS Finalizes Rule Changing The Next Round Of The Competitive Bidding Program And Updating Other Provisions Related To Provider Enrollment And Prior Authorization

Published in Government Relations on December 01, 2025

Final Rule Analysis from the VGM Payer Relations and Reimbursement team 

On Nov, 28, 2025, CMS finalized Final Rule CMS-1828-F that includes updates to the Competitive Bidding Program (CBP) and other provisions related to provider enrollment and prior authorization. Next round is expected to be implemented no later than Jan. 1, 2028. 

CMS has also announced product categories for the new Remote Item Delivery (RID) CBP and an estimated timeline for the next round as whole in a fact sheet. The fact sheet lists the RID CBP product categories to be included in the next round and also indicates that in late spring/early summer 2026, DMEPOS CBP product categories will be announced along with the number of contracts to award for each product category for the program as a whole. 

Final Rule highlights:

New CBP Product Categories 
  • Ostomy, tracheostomy, and urological supplies 
    • Definitions were revised to categorize each as medical equipment and thus subject to CBP inclusion 
  • Continuous glucose monitoring (CGM) and insulin pumps 
    • Class II reclassified under the Frequent and Substantial Servicing (FSS) payment category 
    • Payment on a bundled monthly rental basis for both CBP and non-CBP areas 
  • Off-the-shelf upper extremity orthotics 
Remote Item Delivery (RID) CBP 
  • Creates a remote item competitive bid program for products that are frequently drop shipped, delivered, or picked up at a contracted supplier location 
  • Products announced via the fact sheet for inclusion in the RID CBP are: 
    • Ostomy 
    • Urological 
    • Hydrophilic urinary catheters 
    • CGM 
    • Off-the-shelf upper extremity orthotic products 
    • Off-the-shelf back and knee orthotic products 
DMEPOS CBP 
  • Product categories not included in the RID program are to be announced early spring/late summer 2026 along with the lead item for each category and the number of contracts to be awarded 
SPA Calculation
  • Revises SPA calculation to use the 75th percentile of winning bids for the lead item instead of the maximum winning bid 
  • Revises the ratio for non-lead items in a product category to be based on the 2015 fee schedule rate for each specific CBA (rather than the national average that was used for Round 2021) 
Contract Award Determinations
  • Limits the required number of contracts to less than ten (10) per each product category 
Bid Limits and Conditions for Awarding Contracts if Savings are Not Expected
  • Items included for the first time: The bid limits would be the then current fee schedule
  • Previously included items: The bid limits would be the most recent SPA for the items plus 10 percent. If it has been more than a year since the SPA was last in effect, the inflation-adjusted SPA plus 10 percent. 
  • In no event would the bid limit be allowed to exceed the unadjusted fee schedule amount 
Financial Documentation Changes
  • Limited to: 
    • A credit report with a numerical credit score and/or rating from one of the four approved credit reporting agencies during the bid window; or if not available, a business credit report showing no data or insufficient information to generate a score or rating plus a personal credit report with a numerical credit score or rating from the bidding entity’s Authorized Official or Delegated Official in the Medicare Provider Enrollment, Chain, and Ownership System (PECOS) 
  • Bid surety bond in the amount of $50,000 for each CBA for which submitting a bid. Bid surety bonds are specific to the CBP and are an additional bond to what is required to maintain billing privileges. 
New Contract Clause 
  • Addition of a new clause allowing CMS to unilaterally terminate or modify supplier contracts if certain conditions are met due to a PHE allowing CMS to revert to the general fee-for-service program requirements.

Other Provisions Outside of CBP 

Accreditation 
  • Requires DME suppliers to get reaccredited annually instead of every three (3) years 
Provider Enrollment 
  • Provides several instances in which PTANs may be revoked retroactively 
  • Requires Authorized Official signature for liability insurance 
Prior Authorization 
  • Creates a prior authorization exemption program of certain DMEPOS products for suppliers that reach an affirmation threshold of 90% 

Education and Resources: 

Webinar this Wednesday, Dec. 3, 11 a.m. CST: Understanding the Final Rule on the DMEPOS Competitive Bidding Program 


Join VGM for a live webinar on Wednesday, Dec. 3 at 11 a.m. CST as we break down the latest updates to the Competitive Bidding Program and what they mean for your business. 

Featured Experts: 

  • Melanie Ewald – VP of Payer Relations & Reimbursement 
  • Ronda Buhrmester – Sr. Director of Payer Relations & Reimbursement 
  • Kelly Grahovac – General Manager, The van Halem Group 

This team has spent countless hours analyzing the Final Rule to provide you with the most accurate and actionable insights. They’ll walk you through the bidding program process and answer your questions live. 

Don’t miss this opportunity to stay informed and prepared! 

Sign up for the webinar here.

The van Halem Group 


If you are interested in the program and want to determine if a bid submission is right for your organization, we can help! The van Halem Group offers consultation services related to Competitive Bid 

Click here.

Competitive Bidding Resource Page 


Visit our Competitive Bidding Resource Page for:

  • Advocacy updates and tools 
  • Industry news and best practices 

We will continue to update this page with additional resources and information as we receive more information. 

From Our Experts

New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries thumbnail New Bipartisan Senate Bill Aims to Improve Access to Diabetes Technology & Education for Medicare Beneficiaries U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME), Cochairs of the Senate Diabetes Caucus, have introduced the Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act, S.4037. VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center thumbnail VGM Reintroduces the Fraud, Waste & Abuse Reporting Resource Center VGM Government Relations is proud to announce the reintroduction of its Fraud, Waste & Abuse (FWA) Reporting Resource Center—a newly refreshed online hub designed to protect the integrity of the DMEPOS industry and reinforce our unwavering commitment to ethical, compliant care. Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical thumbnail Celebrating Another DME Champion of Change: Thom Harvill of Above and Beyond Medical We're proud to once again recognize a true Champion of Change in the DME industry: Thom Harvill of Above and Beyond Medical in Tennessee. Thom has dedicated many years to the DME community—consistently showing up, speaking out, and pushing the industry forward. He's the kind of advocate who never stops asking, “Who else can I reach out to about this?” Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart.